Loomis, Sayles & Company’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
Other funds holding EHC
Loomis, Sayles & Company's EHC Position: Q2 2026 in Review
Loomis, Sayles & Company increased its Encompass Health (EHC) stake by 46% in Q2 2026, buying an estimated $3.48M and bringing the position to 106,093 shares worth $10.7M. The position accounts for 0.01% of the portfolio, ranked #378.
Loomis, Sayles & Company first reported a position in EHC in Q2 2015 and has held it in 29 quarters since. The position peaked at $18.9M in Q1 2021. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.
- Loomis, Sayles & Company held 106,093 shares of Encompass Health worth $10.7M as of Q2 2026.
- Loomis, Sayles & Company bought 33,605 Encompass Health shares in Q2 2026, an estimated $3.48M.
- Encompass Health made up 0.01% of Loomis, Sayles & Company's portfolio in Q2 2026, its #378 holding.
- Loomis, Sayles & Company first reported a position in Encompass Health in Q2 2015 and has held it in 29 quarters since.
- Loomis, Sayles & Company's Encompass Health position peaked at $18.9M in Q1 2021.
- 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.
Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.